Compare ARK Genomic Revolution ETF (ARKG) vs Yum! Brands, Inc. (YUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Yum! Brands, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $40.59, while Yum! Brands, Inc. trades at $163.36 (market cap $45.08B). The key difference: Yum! Brands, Inc. pays a 1.83% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | YUM | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $168.16 |
52-Week Low | $23.09 | $138.21 |
Market Cap | — | $45.08B |
Enterprise Value | — | $56.34B |
Dividend Yield | — | 1.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
YUM trades at $163.54, up 0.71% with bullish technical signals and strong support at $158. Revenue grew to $8.21B in 2025 with a 20.48% net margin, though profit margins have slightly declined. The recent $2.7B Pizza Hut sale and $4B buyback authorization highlight strategic focus on KFC and Taco Bell growth. Cash flow from operations remains robust at $2.01B, supporting dividend payments and debt management.
Outlook is positive with analyst consensus target of $174 offering 6.4% upside, but high debt levels and competitive pressures pose risks. The stock's valuation at 26.38 P/E requires sustained earnings growth to justify further gains, making execution on digital initiatives and international expansion critical near-term catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Yum! Brands, Inc.
Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →
